MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 80 filers reported holding MOLECULAR TEMPLATES INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $739 | -100.0% | 2,253 | +12.3% | 0.00% | – |
| Q3 2022 | $1,505,000 | -94.4% | 2,007 | -93.2% | 0.00% | – |
| Q2 2022 | $27,023,000 | +0.4% | 29,643 | +279.9% | 0.00% | – |
| Q1 2022 | $26,920,000 | -48.6% | 7,803 | -41.6% | 0.00% | – |
| Q4 2021 | $52,414,000 | +15.6% | 13,371 | +97.9% | 0.00% | – |
| Q3 2021 | $45,339,000 | +307.1% | 6,757 | +374.5% | 0.00% | – |
| Q2 2021 | $11,136,000 | -74.8% | 1,424 | -59.3% | 0.00% | – |
| Q1 2021 | $44,157,000 | -5.7% | 3,499 | -29.9% | 0.00% | – |
| Q4 2020 | $46,837,000 | -29.7% | 4,988 | -18.3% | 0.00% | – |
| Q3 2020 | $66,634,000 | +414.6% | 6,102 | +549.8% | 0.00% | – |
| Q2 2020 | $12,949,000 | -84.2% | 939 | -84.7% | 0.00% | – |
| Q1 2020 | $81,787,000 | +93.0% | 6,154 | +103.1% | 0.00% | – |
| Q4 2019 | $42,375,000 | +187.2% | 3,030 | +35.3% | 0.00% | – |
| Q3 2019 | $14,755,000 | +2.0% | 2,239 | +29.3% | 0.00% | – |
| Q2 2019 | $14,462,000 | -9.1% | 1,732 | -36.7% | 0.00% | – |
| Q1 2019 | $15,902,000 | +585.7% | 2,737 | +376.8% | 0.00% | – |
| Q4 2018 | $2,319,000 | +45.8% | 574 | +94.6% | 0.00% | – |
| Q3 2018 | $1,590,000 | +2.4% | 295 | -0.7% | 0.00% | – |
| Q2 2018 | $1,553,000 | – | 297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,137,991 | $8,381,000 | 6.85% |
| ACUTA CAPITAL PARTNERS, LLC | 322,500 | $1,264,000 | 0.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,021,317 | $4,004,000 | 0.46% |
| BVF INC/IL | 3,129,599 | $12,268,000 | 0.44% |
| Bellevue Group AG | 10,878,003 | $42,642,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 1,374,047 | $5,386,000 | 0.42% |
| Endurant Capital Management LP | 268,375 | $1,052,000 | 0.25% |
| Abingworth LLP | 200,000 | $780,000 | 0.19% |
| Parkman Healthcare Partners LLC | 147,728 | $579,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 145,329 | $570,000 | 0.07% |